SCHEMBL4151055

SCHEMBL4151055

OCCOc1ccc(N2CC[N]CC2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 1/20 0.40
TIPARP Q7Z3E1 2/20 0.39
MAPT P10636 4/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HTR1A P08908 1/20 0.38
HTR7 P34969 1/20 0.38
ACACB O00763 3/20 0.36
MAPK14 Q16539 1/20 0.36
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
SYK P43405 1/20 0.35
GRM5 P41594 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4137594 0.83 HTR1A (0.44) ALDH1A1SMN1; SMN2LMNAMAPTTSHR
SCHEMBL4136873 0.83 ACACB (0.44) ALDH1A1SMN1; SMN2LMNAMAPTTSHR
SCHEMBL30221911 0.72 HTR1A (0.44) ALDH1A1HTR1AHTR7
SCHEMBL17543935 0.72 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNAMAPTTSHR
SCHEMBL8257341 0.72 HTR1A (0.44) ALDH1A1HTR1AHTR7
SCHEMBL17543960 0.72 PDE3B (0.36) ALDH1A1SMN1; SMN2LMNAACACBHRH3
SCHEMBL1447764 0.72 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNAMAPTMEN1
SCHEMBL30368255 0.71 MAOB (0.49) ALDH1A1SMN1; SMN2PDK1PDK2PDK3
SCHEMBL21490294 0.71 MAOB (0.49) ALDH1A1SMN1; SMN2PDK1PDK2PDK3
SCHEMBL8275462 0.69 HTR1A (0.53) ALDH1A1SMN1; SMN2LMNAMAPTHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases BETSCHART CLAUDIA 2009-02-26 US disclosed
US-7452886-B2 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2008-11-18 US disclosed
EP-1423391-B8 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2007-12-12 EP disclosed
EP-1423391-B1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2006-05-17 EP disclosed
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases NOVARTIS AG (CH) 2005-03-10 US disclosed
EP-1423391-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES Novartis AG (CH) 2004-06-02 EP disclosed
WO-2003020721-A1 PYRROLO PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CYSTEIN PROTEASES NOVARTIS AG (CH) 2003-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054851-A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases CTSK, CTSS, CTSZ ALDH1A1 2931/4885SMN1; SMN2 4708/4885LMNA 4184/4885
US-20090054467-A1 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases CTSK, CTSS, CTSZ ALDH1A1 2931/4885SMN1; SMN2 4708/4885LMNA 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.